XTX Topco’s Altamira Therapeutics Ltd CYTO Stock Holding History

XTX Topco’s Portfolio CYTO Stock Details CYTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,926	Closed	-$1.21K	–	3312
2024 Q4	$1.21K	Buy	+10,926	New	+$5.5K	﹤0.01%	2214
2023 Q4	–	Sell	-507	Closed	-$2.44K	–	2304
2023 Q3	$2.44K	Buy	+507	New	+$3.6K	﹤0.01%	1489

XTX Topco's CYTO Position: Q1 2025 in Review

XTX Topco sold out of Altamira Therapeutics Ltd (CYTO) in Q1 2025, closing a stake of 10,926 shares — an estimated $1.21K sold.

XTX Topco first reported a position in CYTO in Q3 2023 and held it in 2 quarters. The position peaked at $2.44K in Q3 2023. 1 fund tracked by Wall St. Rank holds CYTO as of Q1 2025.

XTX Topco reported no remaining Altamira Therapeutics Ltd position as of Q1 2025 after selling out during the quarter.
XTX Topco sold 10,926 Altamira Therapeutics Ltd shares in Q1 2025, an estimated $1.21K.
XTX Topco first reported a position in Altamira Therapeutics Ltd in Q3 2023 and held it in 2 quarters.
XTX Topco's Altamira Therapeutics Ltd position peaked at $2.44K in Q3 2023.
1 fund tracked by Wall St. Rank held Altamira Therapeutics Ltd as of Q1 2025.

Based on XTX Topco's 13F filing for Q1 2025, filed 8 May 2025.